Jessica Shearer

[Jessica Shearer @JessicaEShearer]

@v_poustie @LynseyC23062813 @NIHRresearch Always an inspiration @LynseyC23062813

[Vanessa poustie @v_poustie]

Lynsey Corless explaining the principles of the @NIHRresearch #AssociatePIScheme and #ResearchLeadershipPathway at #NIHRN2R23 workshop on how to access research training in NHS service roles

[Elliot Tapper @ebtapper]

Predicting clinical events like #cirrhosis decompensations - ascites, bleeding, encephalopathy - with noninvasive tests

FIB-4, fibroscan, and FAST in centers from the USA and Singapore

Open access in @HepCommJournal https://t.co/nrN6MDwBc9 #livertwitter

[Newcastle Liver Unit @LiverUnit]

5 years of HCV testing & treatment in NE England Prisons. Great Collaborative working.
-High rate of testing & treatment
-HCV viraemia⬇️
-Progress towards Elimination
@NuthHCVTeam @HepatitisCTrust

Journal of Viral Hepatitis | Wiley Online Library https://t.co/ceA9S9SPWu

[Frontline Gastro @FrontGastro_BMJ]

Excellent review article on Alcohol-related Hepatitis with diagnostic and treatment algorithms by @JessicaEShearer & @DrStevenMasson https://t.co/fPVPXeZWwq
@BSGTrainees @BritSocGastro @BASLedu @RMBeattie50 #Livertwitter

[Jessica Shearer @JessicaEShearer]

@IQILS_Liver @Drfattyliver @YSTeachingNHS Congratulations! You all look terribly serious here!

[Ian Rowe @IanARowe]

This in @HepCommJournal is important

Echoes findings from our cohort reported by @JessicaEShearer in @AGA_CGH

https://t.co/cA0eYNOR4P

Progression to cirrhosis in #NAFLD / #MASLD is a surrogate endpoint and will overestimate true clinical benefit of pharmacological treatments

[BSG @BritSocGastro]

. @NIHRresearch would like to hear from Gastroenterology trainees regarding Clinical Trials, any barriers to involvement and where you feel the NIHR may be able to support trainee involvement.

@ResearchBsg @BSGTrainees
https://t.co/GLRqFJsjoD

[BASL @basl_events]

❗️BASL X-tra
🤝 Virtual meeting
📆25, 26 and 27 April 2023
📜Liver disease in elderly, controversies in hepatology and Ascites/Portal hypertension symposium
https://t.co/7anAfKFLko
Register 👉 https://t.co/gRWIC797Nv

[Aaron Bancil @AaronBancil]

An amazing line-up of speakers, from expert Professors, to superstar trainees, giving tips and tricks on how to successfully take part in Gastroenterology and Hepatology research #BSGTrainees
Check out the programme ➡️ https://t.co/qfb3mv0cRZ

[Oliver Tavabie @OTavabie]

Great to see this in print - fantastic achievement for the @BASLedu trainee committee @NadirAbbas_X @brennap9 @hrmcdowell1 @janu_navaratnam @anjugsp @dr_robertscott @JessicaEShearer #helenwhite with specific kudos to @Drwenhaoli for his leadership and figures! A few thoughts

[Wenhao Li @Drwenhaoli]

Delighted to see this work from @BASLedu Trainees' Committee out today in @FrontGastro_BMJ! We report the results from the UK national trainee survey of hepatology training, research and the future workforce https://t.co/d1zVLouuou

[Journal of Hepatology @JHepatology]

#Carvedilol
➡️non-selective #βblocker
✅associated with reduced risk of decompensating events
➡️improved survival in patients with #cirrhosis & #portalhypertension

Read it here👉https://t.co/yy8DIJSSEl

#LiverTwitter

[Ian Rowe @IanARowe]

Good discussion of NITs in #NAFLD and #ArLD

As @MajaThiele says, need to move away from the link to fibrosis stage and towards prognosis

NITs are good for prediction of future events and that's what really matters!

See work from @JessicaEShearer in @AGA_CGH

#TLM22

[Thomas Reiberger @ReibergerThomas]

Q: Does my #cACLD patient suffer from #portalhypertension?
A: Impute #platelets, #bilirubin, #INR (or alternatively aPTT, CHE, GGT) into our simple model - and know the likelihood of #CSPH and risk for decompensation.
Great Multicenter Effort @JHepatology
https://t.co/mgYHEVrckB

[Lynsey C @lynseycorless]

Terrific #BASL2022 with some great contributions from the @HullHospitals team (@JessicaEShearer @TaniaNurun and @DiBackhouse), most notably a powerful talk from the relative of a patient about supporting a loved one with liver disease - thank you so much Jane. @basl_events

[Jessica Shearer @JessicaEShearer]

@IanARowe @drrichardparker @LeedsHospitals @LeedsMedHealth Congratulations and well deserved @drrichardparker

[Ian Rowe @IanARowe]

Pleased to say that @drrichardparker has won the #BASL2022 oral presentation award for this work @LeedsHospitals @LeedsMedHealth

Congratulations to him and the rest of the team

If you want to turn your city into hexagons, get in touch!

[BASL education feed @BASLedu]

@drrichardparker from @leeds_liver showing us variation in, and distribution of, risk factors for liver disease across #Leeds

#BASL2022

[BASL education feed @BASLedu]

Dr Lynsey Corless on research in hepatology at #BASL2022
- PPI needs to be at every stage of research.
- it is critical that research is brought into clinical services.
- research needs to be part of core activity.